Ketorolac 30 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB26FKXVQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,088
Award facts
- Contract value 100% obligated
- $5,088.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,088 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ketorolac 30 mg/ml vials. The award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical supply chain, with its IDC ceiling valued at $499,999,999 through December 31, 2036, featuring a 30-month base period and three 30-month option periods. The contractor's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, supporting the diverse pharmaceutical requirements of military healthcare operations globally. The company's demonstrated performance on numerous delivery orders across multiple therapeutic categories, combined with its woman-owned small business status and established presence in federal contracting since 2001, positions it as one of multiple regional prime vendor contractors within the PPV-G GEN V framework.
Quick answers
Who was awarded contract SPE2DB26FKXVQ?
SPE2DB26FKXVQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FKXVQ worth?
The government has obligated $5,088 on SPE2DB26FKXVQ.
Is contract SPE2DB26FKXVQ an order under another contract?
Yes. SPE2DB26FKXVQ is a delivery order under SPE2DB24D9801, an indefinite delivery contract.
Was contract SPE2DB26FKXVQ competed?
The extent of competition for SPE2DB26FKXVQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award